{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "A",
          "alt": "G",
          "position": "244"
        },
        "variant_string_id": "PINK1 A244G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Wild-type but not mutant PINK1 has been shown to protect cells from staurosporine-induced apoptosis.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism involves the loss of PINK1's protective role against apoptosis, relevant to Parkinson's disease pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay used is a cell viability assay measuring apoptosis through TUNEL and caspase-3 activation.",
          "judgment": "Yes",
          "reasoning": "Cell viability assays are appropriate for modeling the loss of function in neurodegenerative diseases like Parkinson's.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The assay included controls and was performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, validating the assay's reliability.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "No specific variant controls were mentioned.",
          "judgment": "No",
          "reasoning": "The paper did not specify the use of known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional assay showed that the PINK1 A244G variant abolishes the protective effect against apoptosis, supporting its pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "V",
          "alt": "I",
          "position": "317"
        },
        "variant_string_id": "PINK1 V317I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Wild-type but not mutant PINK1 has been shown to protect cells from staurosporine-induced apoptosis.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism involves the loss of PINK1's protective role against apoptosis, relevant to Parkinson's disease pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay used is a cell viability assay measuring apoptosis through TUNEL and caspase-3 activation.",
          "judgment": "Yes",
          "reasoning": "Cell viability assays are appropriate for modeling the loss of function in neurodegenerative diseases like Parkinson's.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The assay included controls and was performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, validating the assay's reliability.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "No specific variant controls were mentioned.",
          "judgment": "No",
          "reasoning": "The paper did not specify the use of known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional assay showed that the PINK1 V317I variant abolishes the protective effect against apoptosis, supporting its pathogenicity."
    }
  ]
}
